AB BioTechnologies, Inc. Unveils $12 Million Dollar Expansion

AB BioTechnologies, Inc. Unveils $12 Million Dollar Expansion

AB BioTechnologies, Inc. (ABB) is adding clinical and small-scale commercial GMP manufacturing to their current development and GLP manufacturing capabilities. Expanding to meet the needs of their clients, ABB is constructing a new state-of-the-art headquarters that's over 23,000 sq. ft. and incorporates some of the latest technologies.

AB BioTechnologies, Inc.™

Booth:
  • 1539

AB BioTechnologies - Understanding the Science™

AB BioTechnologies, Inc. (AB) is a contract development and manufacturing organization (CDMO) located in Bloomington, Indiana. AB is an internationally renowned leader in lyophilization and formulati...AB BioTechnologies, Inc. (AB) is a contract development and manufacturing organization (CDMO) located in Bloomington, Indiana. AB is an internationally renowned leader in lyophilization and formulation development for small and large molecules, suspensions, emulsions, tissues, and diagnostic products. The company offers corresponding process development and analytical services as supplements and standalone projects. AB's clients receive dedicated attention from scientists who understand the science behind their products. From early-stage development work to GMP manufacturing, AB's experienced team bring client projects from concept to clinic.More

View Company Profile

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.